New · CUSIP 10919W405 · who reports it, how much, and how much it matters to them
24 of the 720 hedge fund managers we track reported shares of Bright Minds Biosciences Inc. (Nasdaq: DRUG) on Form 13F for 30 June 2026. Between them they reported USD 243m. The largest position belongs to Cormorant Asset Management, at USD 63m. The manager with the most riding on it is Acuta Capital Partners, where it is 4.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Cormorant Asset Management1 fund on PPLI.com | USD 63m | 3.2% |
| 2 | Braidwell12 funds on PPLI.com | USD 34m | 1.3% |
| 3 | Balyasny Asset Management25 funds on PPLI.com | USD 24m | 0.0% |
| 4 | Adage Capital Management1 fund on PPLI.com | USD 24m | 0.0% |
| 5 | POINT72 Asset Management17 funds on PPLI.com | USD 23m | 0.0% |
| 6 | Ra Capital Management1 fund on PPLI.com | USD 19m | 0.2% |
| 7 | Great Point Partners2 funds on PPLI.com | USD 7.7m | 1.5% |
| 8 | Orbimed Advisors1 fund on PPLI.com | USD 6.5m | 0.1% |
| 9 | Acuta Capital Partners2 funds on PPLI.com | USD 6.5m | 4.5% |
| 10 | Sio Capital Management4 funds on PPLI.com | USD 5.2m | 0.9% |
| 11 | Millennium Management6 funds on PPLI.com | USD 4.7m | 0.0% |
| 12 | Citadel Advisors32 funds on PPLI.com | USD 4.7m | 0.0% |
| 13 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4.7m | 0.0% |
| 14 | Walleye Capital8 funds on PPLI.com | USD 4.6m | 0.0% |
| 15 | Artia Global Partners1 fund on PPLI.com | USD 2.7m | 0.5% |
| 16 | Superstring Capital Management1 fund on PPLI.com | USD 2.1m | 1.4% |
| 17 | Boothbay Fund Management2 funds on PPLI.com | USD 2m | 0.0% |
| 18 | Aquatic Capital Management3 funds on PPLI.com | USD 1.5m | 0.1% |
| 19 | Platinum Investment Management11 funds on PPLI.com | USD 1.3m | 0.3% |
| 20 | Exome Asset Management2 funds on PPLI.com | USD 710,000 | 0.4% |
| 21 | Two Sigma Investments35 funds on PPLI.com | USD 674,000 | 0.0% |
| 22 | Tudor Investment Corporation10 funds on PPLI.com | USD 582,000 | 0.0% |
| 23 | Engineers Gate Manager1 fund on PPLI.com | USD 380,000 | 0.0% |
| 24 | The Quarry1 fund on PPLI.com | USD 1,895 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Acuta Capital Partners | USD 6.5m | 4.5% |
| 2 | Cormorant Asset Management | USD 63m | 3.2% |
| 3 | Great Point Partners | USD 7.7m | 1.5% |
| 4 | Superstring Capital Management | USD 2.1m | 1.4% |
| 5 | Braidwell | USD 34m | 1.3% |
| 6 | Sio Capital Management | USD 5.2m | 0.9% |
| 7 | Artia Global Partners | USD 2.7m | 0.5% |
| 8 | Exome Asset Management | USD 710,000 | 0.4% |
| 9 | Platinum Investment Management | USD 1.3m | 0.3% |
| 10 | Ra Capital Management | USD 19m | 0.2% |
Bright Minds Biosciences Inc. trades under the symbol DRUG on the Nasdaq. Its CUSIP, the code used on Form 13F, is 10919W405.
24 of the 720 hedge fund managers PPLI.com tracks reported Bright Minds Biosciences Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 63m), Braidwell (USD 34m), Balyasny Asset Management (USD 24m), Adage Capital Management (USD 24m) and POINT72 Asset Management (USD 23m).
24 managers in our coverage reported it, and between them they run 209 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Acuta Capital Partners, where the position was 4.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Bright Minds Biosciences Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.